ABIOMED
Abiomed is a provider of mechanical circulatory support devices and offers a continuum of care to heart failure patients. The Company develops, manufacture and market products that is designed to enable the heart to rest, heal and recover by improving blood flow and/or performing the pumping function of the heart. The Company's products are used in the cardiac catheterization lab (cath lab) by interventional cardiologists and in the heart surgery suite by heart surgeons for patients who are in need of hemodynamic support prophylactically or emergently before, during or after angioplasty or heart surgery procedures.
ABIOMED
Industry:
Health Care Medical Medical Device
Founded:
1981-01-01
Address:
Danvers, Massachusetts, United States
Country:
United States
Website Url:
http://www.abiomed.com
Total Employee:
501+
Status:
Active
Contact:
(978) 646-1400
Email Addresses:
[email protected].
Total Funding:
0
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager Content Delivery Network Domain Not Resolving
Current Advisors List
Current Employees Featured
Founder
Stock Details
Acquisitions List
Date | Company | Article | Price |
---|---|---|---|
2021-06-01 | preCARDIA | preCARDIA acquired by Abiomed | N/A |
2020-04-29 | Breethe | Breethe acquired by Abiomed | N/A |
2014-07-01 | ECP Entwicklungsgesellschaft | ECP Entwicklungsgesellschaft acquired by Abiomed | 13 M USD |
2005-04-28 | Impella Cardiosystems | Impella Cardiosystems acquired by Abiomed | N/A |
Investors List
EW Healthcare Partners
EW Healthcare Partners investment in Post-IPO Equity - Abiomed
Investments List
Date | Company | Article | Money raised |
---|---|---|---|
2022-05-12 | Impulse Dynamics | Abiomed investment in Venture Round - Impulse Dynamics | 101 M USD |
2019-12-03 | Impulse Dynamics | Abiomed investment in Series D - Impulse Dynamics | 80.25 M USD |
2018-12-06 | Shockwave Medical | Abiomed investment in Series D - Shockwave Medical | 15 M USD |
2018-09-13 | RenalGuard Solutions | Abiomed investment in Series B - RenalGuard Solutions | 7 M USD |
2018-09-13 | Protembis | Abiomed investment in Series A - Protembis | 10 M USD |
2018-09-12 | Reprieve Cardiovascular | Abiomed investment in Venture Round - Reprieve Cardiovascular | 7 M USD |
2017-09-28 | Magenta Medical | Abiomed investment in Series B - Magenta Medical | 15 M USD |
2017-04-11 | ALung Technologies | Abiomed investment in Series C - ALung Technologies | 36 M USD |
Key Employee Changes
Date | New article |
---|---|
2020-06-15 | Abiomed appoints new chief medical officer |
Official Site Inspections
http://www.abiomed.com Semrush global rank: 343.51 K Semrush visits lastest month: 174.31 K
- Host name: 104.16.213.111
- IP address: 104.16.213.111
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago